( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

 ISSN 2394-3211

Impact Factor: 7.065

 ICV - 79.57



Dr. Deshpande Vaishali Shailesh*, Deshpande Shailesh Vinayak, Prof. Kohli Kuldeep Raj, Tamoli Sanjay and Prof. Sakapal Shashikant S


Background: Incidence of Diabetic Nephropathy (DN) in on a rise with increased incidence of Diabetes mellitus. Derangement of renal function leads to end stage renal disease and dialysis or renal replacement remains the only remedy. Though angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blocker (ARB) are used in DN, these have their limitations. Objectives: To evaluate efficacy and safety of Gokshhura (T. terrestris) ghana tablets in Diabetic nephropathy. Methodology: Prospective, randomised, single blind, placebo controlled pilot clinical study was conducted. 57 patients of DN (35 to 70 years both ages inclusive), with raised 24-hour urinary protein and decreased creatinine clearance were screened. 42 patients were randomised in two groups. Group A received Gokshur ghana tablets one gram and group B received placebo, four times a day with water. Visits were at an interval of every four weeks, till 12 weeks. 24-hour urinary protein, creatinine clearance, haemogram, hepatic profile and glycosylated haemoglobin were measured at baseline and after 12 weeks, while renal profile, blood sugar and other clinical symptoms and examinations were measured at every 15 days visit. Results: Significant difference was seen in the treatment group in mean- 24-hour urinary protein (p<0.05), indicating decrease in protein loss, while no significant difference was seen in creatinine clearance (p>0.05). In the placebo group, increased 24-hour urinary protein (p>0.05) was seen and significant decrease in creatinine clearance was observed (p<0.05). Analysis between the groups did not show significant difference. Conclusion: The study concludes that consumption of Gokshura in a dose of 1 gm four times a day may help in in reducing protein loss and preserving renal functions.

Keywords: Kidney disease, renal function, decreased glomerular filtration, protein loss, Prameha Upadrava, ayurveda.

[Full Text Article] [Download Certificate]


  All Since 2019
 Citation  3086  2560
 h-index  18  17
 i10-index  64  44



  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 May 2024 Issue has been Published, Kindly check it on


    MAY 2024 issue has been successfully launched on MAY 2024.

  • EJPMR New Impact Factor

    EJPMR Impact Factor has been Increased to 7.065 for Year 2024.

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI ) Scope Database Academia